Biovail to sell Spectral's tests in Canada:
This article was originally published in Clinica
Executive Summary
Biovail subsidiary Crystaal is to market Spectral Diagnostics' rapid test panel of cardiac markers in Canada. Crystaal has a national sales operation which is focused on cardiovascular and acute care hospitals and will replace Toronto-based Spectral's own direct selling effort, though Spectral will continue to provide support.